# Transmaculine One-on-One and Group Empowerment for Targeted HIV Reduction

> **NCT06182280** · NA · NOT_YET_RECRUITING · sponsor: **Fenway Community Health** · enrollment: 375 (estimated)

## Conditions studied

- HIV Infections
- Adherence, Medication

## Interventions

- **BEHAVIORAL:** PrEP4T
- **BEHAVIORAL:** LS4TM

## Key facts

- **NCT ID:** NCT06182280
- **Lead sponsor:** Fenway Community Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01
- **Primary completion:** 2026-07
- **Final completion:** 2027-06
- **Target enrollment:** 375 (ESTIMATED)
- **Last updated:** 2023-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06182280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06182280, "Transmaculine One-on-One and Group Empowerment for Targeted HIV Reduction". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06182280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*